Studies have shown that TGF-β released by tumor cells activated the p38-MAPK pathway in CAFs, increasing the levels of chemokines such as CXCL10, IL-6, and IL-8, thereby inducing glycogen catabolism in tumor cells (Coller, 2019). The gene discussed is TGFB1; the disease is neoplasm.